YXYunpeng Xu

Yunpeng Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yunpeng Xu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Jialin Fan

    School of Arts and Sciences, Chemistry and Chemical Biology Cancer Institute of New Jersey (CINJ), Director’s Office Cancer Institute of New Jersey (CINJ), Rutgers University

    5 shared publications
  • Zara Khanzada

    Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, NJ 08854, USA

    3 shared publications
  • Guimei Zhang

    Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Jilin University

    1 shared publication
  • Jiang-An Yin

    Institute of Neuropathology, University of Zurich, CH-8091 Zurich, Switzerland

    1 shared publication
  • Mark Youssef

    Department of Molecular Biology and Biochemistry, Rutgers University

    1 shared publication
  • Meng Liu

    Department of Anatomy and Bakar Aging Research Institute, University of California

    1 shared publication

Latest Publications

  • Open Access

    Roles of microRNA in aging and dietary restriction-induced longevity

    by Jialin Fan, Guimei Zhang, Shuo Sun, Xiaowen Zhang, Yaping Li, Meng Liu, Peilin Xu, Mark Youssef, Zara Khanzada, Yifei Zhou, et al.

    Aging is a multifactorial biological process driven by the progressive decline of cellular and tissue homeostasis. Increasing evidence has identified microRNAs (miRNAs) as key epigenetic regulators that fine-tune gene expression networks involved in aging and lifespan determination. Across model organisms—including Caenorhabditis elegans, Drosophila melanogaster, and mammals—numerous miRNAs exhibit age-dependent expression patterns and modulate longevity by targeting conserved signaling pathways such as insulin/IGF-1 signaling, mTOR, autophagy, mitochondrial homeostasis, and inflammatory responses. These small non-coding RNAs function as network regulators that coordinate multiple biological processes underlying organismal aging. In addition to regulating intrinsic aging pathways, miRNAs have emerged as important mediators of environmental longevity interventions. Moreover, dietary restriction (DR), one of the most robust and evolutionarily conserved lifespan-extending interventions, reshapes miRNA expression programs that control metabolic adaptation, stress resistance, and nutrient-sensing pathways. Furthermore, accumulating evidence indicates that circulating miRNAs detected in body fluids—including blood, serum, and urine—may serve as minimally invasive biomarkers for biological aging and age-related diseases. In this review, we summarize current insights into the roles of miRNAs in lifespan regulation across model organisms, discuss their involvement in DR-mediated longevity, and highlight their emerging applications as diagnostic biomarkers and potential therapeutic targets. Finally, we discuss future directions emphasizing integrative multi-miRNA regulatory networks and miRNA-based aging clocks, which may provide new opportunities for understanding aging mechanisms and developing strategies to promote healthy longevity.


  • Top Cited Papers
    Open Access

    Molecular mechanisms underlying the lifespan and healthspan benefits of dietary restriction across species

    by Jialin Fan, Yunpeng Xu

    Dietary restriction (DR), defined as reduced caloric intake or selective limitation of specific nutrients without malnutrition, is one of the most robust interventions known to extend lifespan and healthspan across species. Studies from yeast to mammals demonstrate that DR elicits conserved genetic, transcriptional, and epigenetic programs that promote cellular maintenance and stress resistance. At the molecular level, DR engages evolutionarily conserved nutrient-sensing pathways, including insulin/IGF-1 signaling (IIS), the mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), and NAD + -dependent sirtuins, which converge on key transcription factors (TFs) and transcriptional coactivators (TCs) to coordinate metabolic and longevity-associated gene expression. Downstream, these pathways enhance autophagy and proteostasis, remodel mitochondrial function and redox balance, reshape immune and inflammatory networks, and induce epigenetic and transcriptional reprogramming. Recent work further highlights amino acid–specific sensing mechanisms, endocrine mediators such as fibroblast growth factor 21 (FGF21), the gut microbiome, circadian regulators, and nuclear pore–associated transcriptional plasticity as integral components of DR responses. Importantly, the physiological outcomes of DR are context dependent and influenced by genetic background, sex, age at intervention, and the type and duration of restriction. In this review, we summarize current knowledge on the genetic and molecular architecture underlying DR-induced longevity and health benefits across species, discuss implications for aging-related diseases, and outline future directions toward precision nutrition and safe translational strategies.


  • Top Cited Papers
    Open Access

    Mechanisms Underlying Muscle-Related Diseases and Aging: Insights into Pathophysiology and Therapeutic Strategies

    by Jialin Fan, Zara Khanzada, Yunpeng Xu

    Skeletal muscle aging and related diseases are characterized by progressive loss of muscle mass, strength, and metabolic function. Central to these processes is mitochondrial dysfunction, which impairs energy metabolism, redox homeostasis, and proteostasis. In addition, non-mitochondrial factors such as muscle stem cell exhaustion, neuromuscular junction remodeling, and chronic inflammation also contribute significantly to muscle degeneration. This review integrates recent advances in understanding mitochondrial and non-mitochondrial mechanisms underlying muscle aging and disease. Additionally, we discuss emerging therapeutic approaches targeting these pathways to preserve muscle health and promote healthy aging.


  • Open Access

    Mechanisms Underlying Muscle-Related Diseases and Aging: Insights into Pathophysiology and Therapeutic Strategies

    by Jialin Fan, Zara Khanzada, Yunpeng Xu

    Skeletal muscle aging and related diseases are characterized by progressive loss of muscle mass, strength, and metabolic function. Central to these processes is mitochondrial dysfunction, which impairs energy metabolism, redox homeostasis, and proteostasis. In addition, non-mitochondrial factors such as muscle stem cell exhaustion, neuromuscular junction remodeling, and chronic inflammation also contribute significantly to muscle degeneration. This review integrates recent advances in understanding mitochondrial and non-mitochondrial mechanisms underlying muscle aging and disease. Additionally, we discuss emerging therapeutic approaches targeting these pathways to preserve muscle health and promote healthy aging.


  • Open Access

    Mechanisms Underlying Muscle-Related Diseases and Aging: Insights into Pathophysiology and Therapeutic Strategies

    by Yunpeng Xu, Jialin Fan, Zara Khanzada

    Skeletal muscle aging and related diseases are characterized by progressive loss of muscle mass, strength, and metabolic function. Central to these processes is mitochondrial dysfunction, which impairs energy metabolism, redox homeostasis, and proteostasis. In addition, non-mitochondrial factors such as muscle stem cell exhaustion, neuromuscular junction remodeling, and chronic inflammation also contribute significantly to muscle degeneration. This review integrates recent advances in understanding mitochondrial and non-mitochondrial mechanisms underlying muscle aging and disease. Additionally, we discuss emerging therapeutic approaches targeting these pathways to preserve muscle health and promote healthy aging.

  • Open Access

    Editorial: Genetic and molecular mechanisms of healthy aging and age-related diseases

    by Yunpeng Xu, Jiang-An Yin, Zhiyong Shao

    The respiratory system is one of the primary areas where aging-related decline is evident. Cellular and functional changes in the airway, particularly in the trachea and bronchus, contribute to diseases such as chronic obstructive pulmonary disease (COPD) and asthma. The trachea and bronchus consist of multiple cell types, but which cells are most susceptible to aging remains unknown. A detailed landscape of gene expression changes at the cell-type level in aging airways is urgently needed. A recent study by Liu and Lu et al, through RNA sequencing and cell-type specific analyses, reveals that the proportion of basal cells, which play a critical role in airway regeneration, decreases significantly with age (doi.org/10.3389/fgene.2023.1120350). This reduction is associated with a weakened ability for tissue repair and regeneration. Moreover, these age-related changes are not limited to the structural components of the airway. Immune regulatory pathways, including TNF and NFkappa B signaling, become increasingly dysregulated with age. This dysregulation leads to heightened inflammation, which can exacerbate chronic respiratory diseases. While these findings are intriguing, they are limited to females, and confirmatory studies are needed to determine if they are consistent in males. Further, it is worthy to validate the relationship between basal cell loss and immune pathway dysfunction. Specifically, it is important to determine whether one drives the other, or if they occur concomitantly during airway aging, and which specific airway aging character is regulated by one or both of them.Sarcopenia is characterized by the loss of muscle mass and strength and affects the mobility and overall life quality of the aging population. Cuproptosis has been implicated in sarcopenia, and identification and validation of cuproptosis-related genes in sarcopenia will offer new insights and could provide therapeutic targets. A study by Zhu et al, through comprehensive bioinformatic analyses of gene expression profiles from muscle biopsies of individuals with sarcopenia and healthy controls, identifies some cuproptosis-related genes including PDHA1, DLAT, PDHB, and NDUFC1 as key biomarkers for diagnosing and potentially treating sarcopenia (doi.org/10.3389/fgene.2023.1136763). These genes are closely linked to mitochondrial energy metabolism, which is crucial for maintaining muscle function. Mitochondrial dysfunction is increasingly recognized as a driving factor in sarcopenia, leading to impaired muscle repair and regeneration. Interestingly, metformin, a drug traditionally used to treat diabetes, has shown promise as a potential therapeutic agent for sarcopenia by targeting mitochondrial pathways. This research underscores the importance of mitochondrial health in combating age-related degenerative diseases and opens a new avenue for sarcopenia treatments.TGF-β, a member of the superfamily of signaling molecules, is pivotal in various biological processes, including development, homeostasis, and pathogenesis. Studies utilizing the model organism C. elegans have significantly advanced our understanding of the role and underlying mechanisms of TGF-β signaling [3]. A review by Yamamoto and Savage-Dunn summarizes recent research on TGF-b pathways in aging and immunity (doi.org/10.3389/fgene.2023.1220068). As organisms age, they experience a decline in physiological functions and an increase in susceptibility to diseases. TGF-β signaling pathway members including TGF-β/Activin and BMP (Bone Morphogenetic Protein), have been identified as key regulators in this process. TGF-β signaling not only influences longevity but also has profound implications for immune system health. This dual role underscores the interconnectedness of aging and immune responses, a phenomenon known as immunosenescence. Research in C. elegans has revealed non-canonical aspects of TGF-β signaling that may be relevant for mammalian systems. For instance, a study highlighted the presence of TGF-β signaling and insulin/IGF-1 signaling (IIS) as fundamental pathways associated with healthy aging, particularly in centenarians. The findings suggest that understanding TGF-β's regulatory mechanisms can lead to insights that may enhance our knowledge of aging and improve health outcomes across species. Overall, the insights gained from TGF-β signaling in C. elegans may be applicable to broader biological contexts, particularly regarding aging and immunity.The integrated stress response (ISR) plays a pivotal role in managing cellular stress through modulating protein synthesis, particularly in response to nutrient limitation and endoplasmic reticulum (ER) stress. Dietary restriction (DR) is a promising way of extending lifespan and preserving healthspan in various species. It is unclear whether ISR is involved in protein synthesis and lifespan extension in model organisms under DR. A study by Ma et al discovered that DR in C. elegans reduces mRNA translation, activates the ISR, and extends the lifespan of the animals (doi.org/10.3389/fcell.2023.1263344). Interestingly, they found that reduced mRNA translation and extended lifespan occur independently of eIF-2α phosphorylation, a key feature of ISR. However, eIF-2α phosphorylation remains crucial for managing ER stress and ensuring normal survival in these animals. This finding suggests that ISR regulates ER stress and longevity via distinct mechanisms. The other regulatory mechanisms such as nutrient sensing pathways and the unidentified substrate(s) of kinases of GCN2 and PEK-1 implied in the study may be more directly involved in promoting longevity. Understanding how different stress response pathways interact during aging could reveal new targets for extending lifespan and improving stress resilience in older individuals.Oxidative stress, characterized by an imbalance between reactive oxygen species (ROS) production and antioxidant...

  • Open Access

    A microRNA switch controls dietary restriction‐induced longevity through Wnt signaling

    by Yunpeng Xu, Zhidong He, Mengjiao Song, Yifei Zhou, Yidong Shen

    EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.